相关实验视频

Updated: Jun 8, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

在IB期胃癌中是否需要辅助疗法:一项回顾性队列研究

Mingyu Gu¹, Binghe Zhao¹, Changda Sui¹

¹Department of General Surgery, The First Medical Center of Chinese, PLA General Hospital, Beijing, China.

Annals of surgical oncology

|November 7, 2024

概括

在胃切除术后的IB期胃癌 (GC) 患者中,辅助疗法没有显著的益处,无法改善无病生存率. 需要进一步的研究来确定可能从这些治疗中受益的特定患者子组.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
手术瘤学手术瘤学

背景情况:

对于IB期胃癌 (GC) 的辅助疗法的益处仍在争论中.
这项研究评估了辅助治疗对IB GC患者胃切除术后IB GC患者的影响.

研究的目的:

评估辅助治疗在IB期胃癌患者中的疗效.
为了确定辅助治疗是否改善胃切除术后的整体存活率 (OS) 和无病存活率 (DFS).

主要方法:

对510期IBGC患者进行胃切除术的回顾性分析.
卡普兰-梅尔法和日志等级测试用于OS和DFS分析.
考克斯回归用于识别独立的预后因素.

主要成果:

接受辅助治疗的患者显示,与单独手术 (86.7%;P<0.05) 相比,5年后的生存率有所改善 (92.9%).
在辅助治疗和单独手术组之间,在5年DFS中没有显著差异 (92.6%对95.0%;P>0.05).
老年被确定为瘤复发的危险因素;没有特定的亚组从化疗中受益.

结论:

由于缺乏DFS益处,在IB GC患者的胃切除术后可能不需要辅助治疗.
目前的辅助治疗策略在减少瘤复发方面没有明显的好处.
需要进行进一步的研究,以确定可能受益于辅助治疗的IB GC患者的子组.

关键词:

辅助疗法是一种辅助疗法.没有疾病的生存率.预后因素是预后因素.复发情况复发情况胃癌IB阶段胃癌IB阶段

更多相关视频

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...